About

Exports In 2022, Curaçao exported N/A in Special Pharmaceuticals, making it the 104th largest exporter of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 153rd most exported product in Curaçao. The main destination of Special Pharmaceuticals exports from Curaçao are: Suriname ($75.4k), Grenada ($27k), Guyana ($6.26k), Jamaica ($5.99k), and Aruba ($579).

The fastest growing export markets for Special Pharmaceuticals of Curaçao between 2021 and 2022 were Suriname ($39.1k), Grenada ($27k), and Netherlands ($1).

The fastest growing import markets in Special Pharmaceuticals for Curaçao between 2021 and 2022 were Hungary ($423k), Canada ($1.01k), and France ($561).

Historical Data

Trade Balance

Color

In N/A, Curaçao exported N/A in Special Pharmaceuticals. The main destinations of Curaçao exports on Special Pharmaceuticals were Suriname ($75.4k), Grenada ($27k), Guyana ($6.26k), Jamaica ($5.99k), and Aruba ($579).

In N/A, Curaçao imported N/A in Special Pharmaceuticals, mainly from Hungary ($514k), United States ($158k), Netherlands ($131k), Austria ($8.91k), and Switzerland ($5.53k).

Explore Visualizations

Export Destinations (NaN)

Import Origins (NaN)

Market Growth

Flow
THE FASTEST GROWING Special Pharmaceuticals EXPORT MARKETS FOR Curaçao WERE (2021 - 2022):
Suriname$39.1k (108%)
Grenada$27k (1%)
Netherlands$1 (4.17%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Special Pharmaceuticals BY Curaçao WERE (2021 - 2022):
India-$40.4k (-100%)
Jamaica-$20.1k (-77.1%)
Peru-$9.06k (-100%)

Change in Exports by Market (undefined - undefined)

Market Concentration

View
Flow
Type
In 2022, Curaçao's main exporting competitors in Special Pharmaceuticals were:
In 2022, Curaçao's main importing competitors in Special Pharmaceuticals were:

Explore Visualizations

Trade Value of Special Pharmaceuticals by Exporters

Potential Exports

Potential Exports

Flow
View
N/A
N/AN/A
N/AN/A

Special Pharmaceuticals’s highest export potential is N/A. With an export gap of N/A.   Special Pharmaceuticals’s highest import potential is N/A with an import gap of N/A.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with